Basis: (FMP quote price / unrounded diluted TTM EPS) / explicitly dated EPS growth percent. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-09-18T18:15:50.379Z.
Calculation as of: 2026-09-18T18:15:50.379Z.
Quote observation: 2026-09-18T18:15:17.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 9b48f62db508c30c3900ea5253145910cc956ecc0d76dd275063bdd80f802346
PEG RATIO
N/A
Medpace Holdings, Inc.
Market Cap
$17.06B
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Medpace Holdings, Inc. (MEDP) | $17.06B | N/A |
| Revvity, Inc. (RVTY)vs › | $15.99B | N/A |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.51B | N/A |
| Solventum Corporation (SOLV)vs › | $15.46B | N/A |
| Exelixis, Inc. (EXEL)vs › | $14.62B | N/A |
| Viatris Inc. (VTRS)vs › | $19.81B | N/A |
| STERIS plc (STE)vs › | $20.13B | N/A |
| Tempus AI, Inc. (TEM)vs › | $13.59B | N/A |
| Charles River Laboratories International, Inc. (CRL)vs › | $13.33B | N/A |
| United Therapeutics Corporation (UTHR)vs › | $20.98B | N/A |
PEG Ratio
N/A
P/E Ratio
35.8
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
